-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
RECURSION PHARMACEUTICALS, INC. quarterly and annual Income Tax Expense (Benefit) history and change rate from 2019 to Q3 2025.
- RECURSION PHARMACEUTICALS, INC. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $3,000, a 98% decline year-over-year.
- RECURSION PHARMACEUTICALS, INC. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $147,000, a 97% increase year-over-year.
- RECURSION PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2024 was $1,127,000, a 72% increase from 2023.
- RECURSION PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2023 was $4,062,000.
- RECURSION PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2022 was $0.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)